RIPK1 and central nervous system cancer: Consistently, RIPK1 knockout reduced N-cadherin expression, a hallmark of epithelial–mesenchymal transition (EMT) in glioma [36, 37], while RIPK1 overexpression increased its expression (Fig. 4F, G), suggesting that RIPK1 promotes an EMT-like phenotype.